Transplantation Proceedings
Volume 42, Issue 1 , Pages 29-34 , January 2010

Preliminary Experience With Alemtuzumab Induction Therapy Combined With Maintenance Low-Dose Tacrolimus Monotherapy in Small-Bowel Transplantation in China

References 

  1. Abu-Emaged KM, Bond G, Reyes J, et al. Intestinal transplantation: a coming of age. Adv Surg. 2002;6:65
  2. Gondolesi G, Fauda M. Technical refinements in small bowel transplantation. Curr Opin Organ Transplant. 2008;13:259
  3. Selvaggi G, Tzakis AG. Small bowel transplantation: technical advances/updates. Curr Opin Organ Transplant. 2009;14:262
  4. Kato T, O'Brien CB, Berho M, et al. Improved rejection surveillance in intestinal transplant recipients with frequent use of zoom video endoscopy. Transplant Proc. 2000;32:1200
  5. Pappas PA, Saudubray JM, Tzakis AG, et al. Serum citrulline and rejection in small bowel transplantation: a preliminary report. Transplantation. 2001;72:1212
  6. Green M, Bueno J, Sigurdsson L, et al. Unique aspects of the infectious complications of intestinal transplantation. Curr Opin Organ Transplant. 1999;4:361
  7. Abu-Elmagd K, Reyes J, Bond G, et al. Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg. 2001;234:404
  8. Reyes J, Mazariegos G, Bond G, et al. History of pediatric organ transplantation: pediatric intestinal transplantation; historical notes, principles and controversies. Pediatr Transplant. 2002;6:193
  9. Abu-Elmagd K, Reyes J, Todo S, et al. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg. 1998;186:512
  10. Pinna AD, Weppler D, Nery JR, et al. Induction therapy for clinical intestinal transplantation: comparison of four different regimens. Transplant Proc. 2000;32:1193
  11. Goulet O, Revillon Y, Brousse N, et al. Successful small bowel transplantation in an infant. Transplantation. 1992;53:940
  12. Grant D. Current results of intestine transplantation. Lancet. 1996;347:1801
  13. Abu-Elmagd K, Costa G, Bond GJ, et al. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Transplant Int. 2009;22:96
  14. Yuanxin Li, Ning Li, Yousheng Li, et al: Improved outcome after isolated small bowel transplantation in China: multicenter report. Presented at the Eleventh International Small Bowel Transplant Symposium; September 9–12, 2009; Bologna, Italy. Abstract OR70
  15. Yuanxin Li, Ning Li, Yousheng Li, et al. Refined surgical technique of isolated small bowel transplantation. Chin J Dig Surg. 2008;7:69
  16. Yuanxin Li, Ning Li, Yousheng Li, et al. Improved perioperative management of small bowel transplantation. Chin J Surg. 2008;46:636
  17. Ruiz P, Bagni A, Brown R, et al. Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the eighth International Small Bowel Transplant Symposium. Transplant Proc. 2004;36:335
  18. Calne R, Moffatt SD, Friend PJ, et al. Alemtuzumab 1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation. 1999;68:613
  19. Morris PJ, Russell NK. Alemtuzumab (Campath-1H): a systematic review in organ transplantation. Transplantation. 2006;81:1361
  20. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet. 2003;361:1502
  21. Tan HP, Kaczorowski DJ, Basu A, et al. Living donor renal transplantation using Alemtuzumab induction and tacrolimus monotherapy. Am J Transplant. 2006;6:2409
  22. Silveira FP, Marcos A, Kwak EJ, et al. Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion. J Infect. 2006;53:241
  23. Malek SK, Obmann MA, Gotoff RA, et al. Campath-1H induction and the incidence of infectious complications in adult renal transplantation. Transplantation. 2006;81:17
  24. Shapiro R, Tan HP, Basu A, et al: Alemtuzumab preconditioning and tacrolimus monotherapy in adult kidney transplant recipients. Program and abstracts of the World Transplant Congress 2006; July 22–27, 2006; Boston, Massachusetts. Abstract 670.

 This study was supported by grant 2008BAI60B06 from the National Key Technologies R&D Program in the Eleventh Five-Year Plan, Ministry of Science and Technology of the People's Republic of China.

PII: S0041-1345(09)01784-9

doi: 10.1016/j.transproceed.2009.12.028

Transplantation Proceedings
Volume 42, Issue 1 , Pages 29-34 , January 2010

Article Tools

* Image Usage & Resolution